NCT06440811: Preoperative Adjuvant SOX Plus PL-1 Antibody and FLOT Plus PD-1 Antibody for Locally Advanced dMMR Gastric Cancer |
|
|
| Recruiting | 1 | 200 | RoW | SOX+PD-1 antibody, SOX+Nivolumab, FLOT+PD-1 antibody, FLOT+Nivolumab | Xijing Hospital | Gastric Cancer, Immune-related Adverse Event, Chemotherapeutic Toxicity | 01/25 | 03/25 | | |
NCT03273920: Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer |
|
|
| Not yet recruiting | N/A | 1110 | RoW | Robotic distal gastrectomy with D2 nodal dissection, Laparoscopic distal gastrectomy with D2 nodal dissection | Southwest Hospital, China, Chinese PLA General Hospital, West China Hospital, Xijing Hospital of Digestive Diseases, Nanjing PLA General Hospital, Peking University Cancer Hospital & Institute, Qingdao University, Fujian Medical University Union Hospital, Central South University, The First Affiliated Hospital of Nanchang University, Sun Yat-sen University, Wuhan Union Hospital, China, Jilin Provincial Tumor Hospital, Lanzhou General Hospital of PLA | Gastric Cancer | 09/19 | 09/22 | | |
NCT06128252: Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer |
|
|
| Recruiting | N/A | 96 | RoW | Taurine, Serplulimab, XELOX regimen, Placebo | Tang-Du Hospital | Gastric Cancer | 06/26 | 06/26 | | |
